The state of the union

Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.

Clinical and experimental dermatology·2021

An exploration of adolescent facial shape changes with age via multilevel partial least squares regression.

Computer methods and programs in biomedicine·2021

Multilevel principal components analysis of three-dimensional facial growth in adolescents.

Computer methods and programs in biomedicine·2019

Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

Lupus·2019

Recipients' and providers' perspectives of obesity and potential barriers to weight management programmes in patients with Rheumatoid Arthritis (RA): a qualitative study.

BMC obesity·2017

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.

Clinical radiology·2017

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Combined signals of scientific and social consensus best mobilize action on societal challenges even if government and industry oppose.

Proceedings of the National Academy of Sciences of the United States of America·2026

Political Contestation of the Right to Health in the United States: Eighty Years of Conservative Opposition to Health and Human Rights.

Health and human rights·2026

[SOCIO-CULTURAL IDENTITY IN THE SYSTEM OF SOCIAL IMMUNITY OF YOUTH].

Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny·2026

Science communication as a wicked problem: Revisiting the paradigms of deficits.

Public understanding of science (Bristol, England)·2026

Regulatory Science: exploring an emerging scientific discipline in health care.

Frontiers in medicine·2026

International collaborative research, systems leadership and education: reflections from academic biomedical researchers in Africa.

Frontiers in education·2026

Related Experiment Videos

The state of the union

Related Concept Videos

Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.

An exploration of adolescent facial shape changes with age via multilevel partial least squares regression.

Multilevel principal components analysis of three-dimensional facial growth in adolescents.

Changing hospitalization trends for systemic lupus erythematosus and rheumatoid arthritis in England.

Recipients' and providers' perspectives of obesity and potential barriers to weight management programmes in patients with Rheumatoid Arthritis (RA): a qualitative study.

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Combined signals of scientific and social consensus best mobilize action on societal challenges even if government and industry oppose.

Political Contestation of the Right to Health in the United States: Eighty Years of Conservative Opposition to Health and Human Rights.

[SOCIO-CULTURAL IDENTITY IN THE SYSTEM OF SOCIAL IMMUNITY OF YOUTH].

Science communication as a wicked problem: Revisiting the paradigms of deficits.

Regulatory Science: exploring an emerging scientific discipline in health care.

International collaborative research, systems leadership and education: reflections from academic biomedical researchers in Africa.

Related Experiment Videos

The state of the union

Related Concept Videos

Related Articles